Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.
about
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expressionAntioxidant enzymes and apoptosis.Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.Treatment of melanoma cells with a bcl-2/bcl-xL antisense oligonucleotide induces antiangiogenic activity.ABT-737 and/or folate reverse the PDGF-induced alterations in the mitochondrial apoptotic pathway in low-grade glioma patients.
P2860
Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Bcl-2 overexpression decreases ...... ancement of catalase activity.
@en
type
label
Bcl-2 overexpression decreases ...... ancement of catalase activity.
@en
prefLabel
Bcl-2 overexpression decreases ...... ancement of catalase activity.
@en
P2093
P2860
P50
P356
P1476
Bcl-2 overexpression decreases ...... hancement of catalase activity
@en
P2093
P2860
P304
P356
10.1002/JCB.1245
P577
2001-08-01T00:00:00Z